Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Watch Ingenta (ING) by Steve Moore in ShareProphets
- Avoid Videndum (VID) by Steve Moore in ShareProphets
- Watch Funding Circle Holdings (FCH) by Mark Hartley in The Motley Fool
- Sell Dr. Martens (DOCS) by Steve Moore in ShareProphets
- Hold Persimmon (PSN) by Berenberg
- Buy Atalaya Mining (ATYM) by Berenberg
- Buy Alfa Financial Software Holdings (ALFA) by Berenberg
- Avoid British American Tobacco (BATS) by Royston Wild in The Motley Fool
- Avoid BP (BP.) by Royston Wild in The Motley Fool
- Avoid BT Group (BT.A) by Royston Wild in The Motley Fool
- Buy RS Group (RS1) by John Ficenec in The Times - Tempus
- Buy Johnson Matthey (JMAT) by Jefferies
- Hold Zigup (ZIG) by Jefferies
- Watch Solid State (SOLI) by Steve Moore in ShareProphets
- Buy Forterra (FORT) by Jefferies
- Buy Conduit Holdings Limited Com Shs (DI) (CRE) by Jefferies
- Buy Intermediate Capital Group (ICG) by Jefferies
- Buy Rolls-Royce Holdings (RR.) by Jefferies
- Buy Persimmon (PSN) by Jefferies
- Avoid Forterra (FORT) by Steve Moore in ShareProphets
AstraZeneca (AZN) Share Price
Health Care Sector
NOTE: This is based on 1,299 open tips for AstraZeneca (AZN)
| Latest Bid : 14,032.00p | Latest Ask : 14,036.00p |
| High Today : 14,064.00p | Low Today : 13,892.00p |
| This Years High : 15,316.00p | This Years Low : 11,460.00p |
| Volume : 522,961 | MKT Cap : £216721M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
AstraZeneca (AZN) Overview
A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.AstraZeneca (AZN) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Hold | Deutsche Bank | Premium Only | 2026-11-06 18:00:00 06/11/2026 | 0.45% |
| Buy | Jefferies | Premium Only | 2026-10-20 13:30:00 20/10/2026 | 12.27% |
| Buy | Berenberg | Premium Only | 2026-10-07 12:00:00 07/10/2026 | 16.57% |
| Outperform | Bernstein | Premium Only | 2026-10-07 09:05:00 07/10/2026 | 17.02% |
| Buy | Goldman Sachs | Premium Only | 2026-09-18 09:28:00 18/09/2026 | 12.07% |
AstraZeneca (AZN) Recent Short Position Updates
| Position | Date | |||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 14,032.00p | Latest Ask : 14,036.00p |
| High Today : 14,064.00p | Low Today : 13,892.00p |
| This Years High : 15,316.00p | This Years Low : 11,460.00p |
| Volume : 522,961 | MKT Cap : £216721M |
AstraZeneca Overview
A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest AstraZeneca Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Hold | Deutsche Bank | Premium Only | 2026-11-06 18:00:00 06/11/2026 | 0.45% |
| Buy | Jefferies | Premium Only | 2026-10-20 13:30:00 20/10/2026 | 12.27% |
| Buy | Berenberg | Premium Only | 2026-10-07 12:00:00 07/10/2026 | 16.57% |
| Outperform | Bernstein | Premium Only | 2026-10-07 09:05:00 07/10/2026 | 17.02% |
| Buy | Goldman Sachs | Premium Only | 2026-09-18 09:28:00 18/09/2026 | 12.07% |